TNKS1/2 inhibitors (Merck Healthcare KGaA)

N/A

Report date: 2025/01/26 16:21:28
NME

Base Information

Drug NameTNKS1/2 inhibitors (Merck Healthcare KGaA)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTankyrase-2 inhibitorsTankyrase-1 inhibitorsWingless type MMTV integration site family protein modulators
TargetsTankyrase-2Wingless type MMTV integration site family proteinTankyrase-1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMerck Healthcare Kgaa
China Registration ClassN/A

Develop Information

Active CompaniesMerck Healthcare Kgaa
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A